Literature DB >> 6378800

Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins.

R A Finkelstein, C V Sciortino, L C Rieke, M F Burks, M Boesman-Finkelstein.   

Abstract

Heat-labile enterotoxins from Escherichia coli strains of porcine and human origin polymerize on heating to form high-molecular-weight aggregates, "procoligenoids," analogous to procholeragenoid derived from the cholera enterotoxin. This aggregation is accompanied by loss of biological activity (toxicity). Further heating results in the release of B-subunit oligomers, coligenoids, analogous to choleragenoid. Further studies are needed to determine whether, like procholeragenoid, the procoligenoids are superior antigens in stimulating gut immunity after parenteral administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378800      PMCID: PMC263278          DOI: 10.1128/iai.45.2.518-521.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Properties of homogeneous heat-labile enterotoxin from Escherichia coli.

Authors:  J D Clements; R J Yancey; R A Finkelstein
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  Conversion of cholera exo-enterotoxin (choleragen) to natural toxoid (choleragenoid).

Authors:  R A Finkelstein; J W Peterson; J J Lospalluto
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

4.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

5.  Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.

Authors:  N F Pierce; W C Cray; J B Sacci
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.

Authors:  N F Pierce; W C Cray; J B Sacci; J P Craig; R Germanier; E Fürer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model.

Authors:  R A Finkelstein; R C Hollingsworth
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

8.  Immunological differences among the cholera/coli family of enterotoxins.

Authors:  B A Marchlewicz; R A Finkelstein
Journal:  Diagn Microbiol Infect Dis       Date:  1983-06       Impact factor: 2.803

9.  Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli.

Authors:  S J Geary; B A Marchlewicz; R A Finkelstein
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  1 in total

1.  Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.

Authors:  M Boesman-Finkelstein; N E Walton; R A Finkelstein
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.